CClinicalTrials.gg
Active, not recruitingNCT03562936NORDSTEN/OSUpdated Aug 16, 2021

The NORDSTEN Studies/The Observational Cohort Study

An observational study in Degenerative Lumbar Spinal Stenosis and Degenerative Spondylolisthesis, sponsored by Haukeland University Hospital. Active, not recruiting at 1 site in Norway. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-08-16.

Sponsored by Haukeland University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
284
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The NORDSTEN- OS(Observational study) aim to study the natural course in patients with mild to moderate symptomatic lumbar spinal stenosis with and without degenerative spondylolisthesis. 10 years follow-up is planned.

The NORDSTEN-OS is one of three studies in The NORwegian Degenerative Spondylolisthesis and Spinal STENosis studies.

The two other studies are:

NORDSTEN-SST (Spinal stenosis trial) (NCT02007083); a randomized controlled trial comparing the clinical and radiological results in three different decompression techniques in patients with lumbar spinal stenosis. The NORDSTEN-DS (Degenerative spondylolisthesis) (NCT02051374); a randomized controlled trial comparing the outcome of surgery with decompression without fixation and decompression with fixation in patients with lumbar spinal stenosis and concurrent degenerative spondylolisthesis.

Read the detailed description

Objectives:

  1. A longitudinal observation of clinical- and radiological development with 5- and 10 years follow-up. Variables predicting clinical deterioration or improvement, and outcome measurements including time from inclusion to time for surgery, will be analyzed. We will use predictive models appropriate to the type of data each prognostic outcome measure represents. For example the repeated pain and disability measures will be analysed using linear mixed models. Logistic regression models with no more than 1 variable per 10 events will be used to analyse associations between prognostic factors and disability. Multivariate analysis will identify the predictive prognostic factors in the demographic, physical, social and radiological domains. The number of factors that will be entered in the multivariate analysis will be condensed by univariate pre-testing and omitting highly correlated factors. The prognostic value of both single and combined variables will be addressed by calculating sensitivity, specificity, positive and negative likelihood ratios in a standard way.

    Time to surgery will be modeled using Kaplan-Meier plot. Depending on number of treated patients the effect of selected covariates on time to surgery will be evaluated using the Cox model.

    1. To investigate differences between patients in the observational cohort and patients treated surgically in NORDSTEN-SST and NORDSTEN-DS, by comparing baseline demographic-, clinical-, and radiological data. Patients in the NORDSTEN-OS with lumbar spinal stenosis and a verified degenerative spondylolisthesis of ≥ 3mm will be compared to patients in the NORDSTEN-DS. Patients in the NORDSTEN-OS with lumbar spinal stenosis without degenerative spondylolisthesis will be compared to patients in the NORDSTEN-SST. We will use descriptive statistics to compare the patient groups. For each of the variables we will compare measures of central tendency such as mean and median, and measures of variability such as variance and quantiles. We will also plot distributions of certain variables using histograms or fitted densities, in order to easier compare and see similarities and differences between the groups.

Baseline data Demographical data: Age, gender, BMI, education and native language. Status regarding: marriage, smoking, work and disability benefits.

Clinical data: duration of symptoms (back pain and leg pain) and use of analgetics, Patient reported outcome measures: Oswestry Disability Index (ODI 2.0), Zurich Claudication Questionnaire, EQ-5D and Numeric Rating Scale for leg pain and back pain. Hopkins symptom check list (HSCL-25) HSCL-25 is a PROM for assessment of psychological variables. It covers emotional distress, scores range from 1 to 4, with lower scores indicating less severe symptoms.

Radiological data: Standing x-rays; anterior-posterior (AP), lateral and functional images (lateral- extension and flexion) and MRI.

Radiological evaluations Standing x-ray with functional images and MRI will be performed at baseline-, 5-, and 10 years follow-up. Additionally, patients with lumbar spinal stenosis and concomitant degenerative spondylolisthesis at baseline undergo functional radiographs at 2 years follow-up. One musculoskeletal radiologist and two surgeons (Orthopedic surgeon and Neurosurgeon) will perform the radiological interpretations using Picture Archiving and Communication System (PACS), Sectra, Sweden.

MRI of the lumbar spine, including T1 and T2 sequences in the axial and sagittal planes. The following variables will be measured:

Measurements quantifying the degree of stenosis:

Morphologic grading according to the method described by Schizas et al. The grading is based on the cerebrospinal fluid/rootlet ratio, and is scaled from A-D, where A is no stenosis, B moderate stenosis, C severe stenosis and D extreme stenosis.

Measurements from sagittal plane T1 MRI sequences for grading of foraminal stenosis using the method of Lee et al.

The presence or absence of redundant nerve root sign.

Measurements when degenerative spondylolisthesis is present:

Measurement of the facet joint orientation will be done by MRI images in the transverse plan using the method of Berleman et al.

Degree of disc degeneration according to Pfirrmann et al and Modic et al. Qualitative measurement of facet joint fluid.

Qualitative measurement of disc height.

Skeletal x-rays:Standard images; frontal and lateral view of L1 to S1 in standing position.Extension- and flexion images; lateral view of L1 to S1 with respectively maximal flexion and maximal extension.

Measurement of lumbar lordosis (L1-S1),sacral slope Measurements from the radiographs for calculating vertebral sagittal olisthesis and segmental instability will use the method of Dupuis et al.

02

Conditions studied

  • Degenerative Lumbar Spinal Stenosis
  • Degenerative Spondylolisthesis

Keywords

  • LSS,DS
03

In context

Spinal Stenosis

459 studies on the registry are indexed under Spinal Stenosis; 103 are open to participants now.

This study's enrollment of 284 is above the median of 116 across 152 observational studies indexed under Spinal Stenosis.

Browse Spinal Stenosis studies →

Lead sponsor

Haukeland University Hospital is the lead sponsor of 276 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients with symptomatic LSS with and without LDS referred to the participating orthopedic- or neurosurgical departments will be eligible for inclusion in the observational cohort. The burden of symptoms is considered not to be severe enough to opt for surgical treatment, and this conclusion is made through informed shared decision-making between surgeon and patient. Patients will be given verbal and written information about this observational study. If willing to participate, the patients sign an informed consent. The treatment of these patients will be pragmatic "usual care". There will not be any planned specific conservative treatment, but the surgeon can recommend specific conservative treatments in any case if preferred

Inclusion criteria

  • Presence of clinical symptoms of spinal stenosis. Neurogenic claudication or radiating pain to one or both lower limbs
  • Radiological findings corresponding to the clinical symptoms of LSS. Central stenosis or lateral recess stenosis with or without degenerative spondylolisthesis
  • Able to understand Norwegian language, both spoken and written
  • Able to give informed consent and to answer the questionnaires
  • Over 18 years of age

Exclusion criteria

Exclusion Criteria:

  • Not willing to give written consent
  • Participation in other clinical trial that may interfere with this trial
  • American Society of Anesthesiologists (ASA) 4 or 5
  • Age older than 80 years
  • Not able to comply fully with the protocol, including treatment, follow-up or study procedures (psychosocially, mentally and physically)
  • Presence of cauda equina syndrome (bowel and bladder dysfunction) or complete motor deficit
  • Presence of an isthmic defect in pars interarticularis
  • Former fracture of the thoracolumbar region
  • Previous surgery in the lumbar region
  • Distinct symptoms in one or both legs due to other diseases, e.g. polyneuropathy, vascular claudication or osteoarthritis
  • Lumbosacral scoliosis of more than 20 degrees verified on standing x-ray AP-view
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
284 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Oswestry Disability Index (ODI) version 2.0

    ODI is a patient reported outcome measure (PROM) comprising 10 sections where the patient is supposed to mark the most appropriate item. ODI scores range from 0 to 100, with higher score indicating more severe pain and disability. ODI is recommended by international expert panels for the evaluation of disability in clinical trials and commonly used by physicians treating patients with back-related symptoms. It has been translated and validated for applications with Norwegian patients. The change in ODI from baseline to follow-up will be registered.

    Time frame: Baseline and follow-up at 2,5 and 10 years

Secondary outcomes

  1. Zürich Claudication Questionnaire (ZCQ)

    A PROM evaluating disorder-specific functional capacity covering three domains: symptom severity (score 1-5), physical function (score 1-4), and patient satisfaction (Score 1-4) The change in ZCQ from baseline to follow-up will be registered

    Time frame: Baseline and follow-up at 2,5 and 10 years

  2. Numeric Rating Scale (NRS) for back and leg pain.

    NRS is a PROM that assesses self-reported pain from 0 (no pain) to 10 (the worst pain imaginable). The change in NRS for back- and leg pain from baseline to follow-up will be registered.

    Time frame: Baseline. Follow-up at 2,5 and 10 years

  3. EuroQol 5 dimensions questionnaire (EQ-5D).

    EQ-5D is a generic PROM for the evaluation of quality of life comprising 5 questions relating to mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. Each question has a three-point descriptive Likert-scale. Patient's answers are transformed into a scale ranging from -0.59 - 1.0 (1 equals perfect health). The change in EQ-5D from baseline to follow-up will be registered.

    Time frame: Baseline and follow-up at 2,5 and 10 years

  4. Time from inclusion until time for to surgery.

    Time frame: 10 years

  5. A questionnaire mapping subjective change of symptoms from baseline in a 6 point response scale, ranging from completely recovered to getting worse.

    Time frame: Follow-up at 2,5 and 10 years

  6. A questionnaire mapping the satisfaction with living with the current state of symptoms for the rest of the life in a 5 point response scale, ranging from very satisfied to very dissatisfied.

    Time frame: Follow-up at 2,5 and 10 years

07

Study locations

1 site
  • Kysthospitalet i Hagavik, Orthopeadic clinic, Haukeland University Hospital
    Hagavik, 5217, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03562936
Lead sponsor
Haukeland University Hospital
Collaborators
Møre og Romsdal Hospital Trust
Responsible party
Sponsor
First posted
Jun 20, 2018
Start date
Feb 2014
Primary completion
Oct 2028 (estimated)
Completion
Oct 2029 (estimated)
Last update
Aug 16, 2021

Study contacts

Frode G Rekeland, MD
principal investigator · Kysthospitalet i Hagavik, Orthopeadic clinic, Haukeland University Hospital
Clemens Weber, PhD, MD
study chair · Stavanger University Hospital, Department for Neurosurgery

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion